Loading clinical trials...
Loading clinical trials...
White Matter Structure and Response to Treatment With Antidepressants: a Study of Desvenlafaxine in Major Depression. A Pilot Study
Conditions
Interventions
Desvenlafaxine
Locations
1
Canada
Centre de Recherche Fernand-Seguin
Montreal, Quebec, Canada
Start Date
November 1, 2011
Primary Completion Date
September 1, 2013
Completion Date
November 1, 2013
Last Updated
December 15, 2011
NCT04480918
NCT06732284
NCT06763081
NCT07111169
NCT06748274
NCT07041073
Lead Sponsor
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions